PharmaShots | Incisive News in 3 Shots

Subscribe Now

CALLIPER Studies

Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE & P-II CALLIPER Studies for RRMS & PMS

Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE & P-II CALLIPER Studies for RRMS & PMS

July 6, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us